Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
3.180
-0.010 (-0.31%)
Nov 20, 2024, 4:00 PM EST - Market open
Marker Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5.4 | 3.31 | 3.51 | 1.24 | 0.47 | 0.21 | Upgrade
|
| Revenue Growth (YoY) | 79.04% | -5.76% | 182.96% | 166.01% | 118.95% | 3.50% | Upgrade
|
| Cost of Revenue | 2.62 | 10.42 | 11.97 | 27.79 | 18.88 | 12.76 | Upgrade
|
| Gross Profit | 2.78 | -7.11 | -8.45 | -26.55 | -18.41 | -12.55 | Upgrade
|
| Selling, General & Admin | 4.59 | 7.48 | 11.34 | 12.92 | 10.47 | 9.98 | Upgrade
|
| Research & Development | 8.38 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 12.97 | 7.48 | 11.34 | 12.92 | 10.47 | 9.98 | Upgrade
|
| Operating Income | -10.19 | -14.58 | -19.79 | -39.48 | -28.89 | -22.53 | Upgrade
|
| Interest & Investment Income | 0.56 | 0.54 | 0.25 | 0.01 | 0.15 | 1.08 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.03 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -9.63 | -14.04 | -19.54 | -39.47 | -28.71 | -21.43 | Upgrade
|
| Other Unusual Items | - | - | -0.23 | -2.41 | - | - | Upgrade
|
| Pretax Income | -9.63 | -14.04 | -19.78 | -41.88 | -28.71 | -21.43 | Upgrade
|
| Income Tax Expense | 0 | 0 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -9.63 | -14.05 | -19.78 | -41.88 | -28.71 | -21.43 | Upgrade
|
| Earnings From Discontinued Operations | -0.06 | 5.81 | -10.15 | - | - | - | Upgrade
|
| Net Income | -9.7 | -8.24 | -29.93 | -41.88 | -28.71 | -21.43 | Upgrade
|
| Net Income to Common | -9.7 | -8.24 | -29.93 | -41.88 | -28.71 | -21.43 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 8 | 8 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 8 | 8 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 2.63% | 5.49% | 9.16% | 62.64% | 3.19% | 138.78% | Upgrade
|
| EPS (Basic) | -1.09 | -0.94 | -3.58 | -5.47 | -6.10 | -4.70 | Upgrade
|
| EPS (Diluted) | -1.09 | -0.94 | -3.59 | -5.47 | -6.10 | -4.70 | Upgrade
|
| Free Cash Flow | -8.57 | -16.44 | -26.97 | -30.41 | -29.29 | -18.66 | Upgrade
|
| Free Cash Flow Per Share | -0.96 | -1.87 | -3.23 | -3.97 | -6.23 | -4.09 | Upgrade
|
| Gross Margin | 51.49% | -214.60% | -240.64% | - | - | - | Upgrade
|
| Operating Margin | -188.94% | -440.37% | -563.28% | -3179.32% | -6188.25% | -10567.28% | Upgrade
|
| Profit Margin | -179.71% | -248.76% | -851.87% | -3372.68% | -6149.74% | -10050.92% | Upgrade
|
| Free Cash Flow Margin | -158.91% | -496.51% | -767.66% | -2449.11% | -6274.32% | -8752.25% | Upgrade
|
| EBITDA | - | -11.79 | -17 | -37.33 | -28.4 | -22.42 | Upgrade
|
| D&A For EBITDA | - | 2.79 | 2.79 | 2.15 | 0.49 | 0.11 | Upgrade
|
| EBIT | -10.19 | -14.58 | -19.79 | -39.48 | -28.89 | -22.53 | Upgrade
|
| Revenue as Reported | 5.4 | 3.31 | 3.51 | 1.24 | 0.47 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.